1st Quarter - Report

THE SHERIDAN GROUP for OFFICE OF LIAISON COUNSEL - MDL 926

Period 1st Quarter 2008 Filed Apr 18, 2008 Signed by THOMAS F. SHERIDAN

Official filing
Firm
THE SHERIDAN GROUP
Client
OFFICE OF LIAISON COUNSEL - MDL 926
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

SILCONE BREAST IMPLANT REGULATIONS; HR2503

LobbyistCovered position, as disclosed
AMY HANSEN —
KEVIN MATHIS —
CHRISTOPHER REVERE —
THOMAS SHERIDAN —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2503 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.